BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 27639528)

  • 21. Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects.
    Jiang Z; Wu M; Miao J; Duan H; Zhang S; Chen M; Sun L; Wang Y; Zhang X; Zhu X; Zhang L
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1710-9. PubMed ID: 23702033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis.
    Benndorf RA; Schwedhelm E; Gnann A; Taheri R; Kom G; Didié M; Steenpass A; Ergün S; Böger RH
    Circ Res; 2008 Oct; 103(9):1037-46. PubMed ID: 18802021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Angiogenic Activity Of Bevacizumab-Bearing Dexamethasone-Loaded PLGA Nanoparticles For Potential Intravitreal Applications.
    Liu J; Zhang X; Li G; Xu F; Li S; Teng L; Li Y; Sun F
    Int J Nanomedicine; 2019; 14():8819-8834. PubMed ID: 31819410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-angiogenic effect of Nelumbo nucifera leaf extracts in human umbilical vein endothelial cells with antioxidant potential.
    Lee JS; Shukla S; Kim JA; Kim M
    PLoS One; 2015; 10(2):e0118552. PubMed ID: 25714482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Manipulation of VEGF-induced angiogenesis by 2-N, 6-O-sulfated chitosan.
    Yu Y; Chen R; Sun Y; Pan Y; Tang W; Zhang S; Cao L; Yuan Y; Wang J; Liu C
    Acta Biomater; 2018 Apr; 71():510-521. PubMed ID: 29501817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular disrupting activity of combretastatin analogues.
    Porcù E; Salvador A; Primac I; Mitola S; Ronca R; Ravelli C; Bortolozzi R; Vedaldi D; Romagnoli R; Basso G; Viola G
    Vascul Pharmacol; 2016 Aug; 83():78-89. PubMed ID: 27235861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemokinins modulate endothelium function and promote angiogenesis through neurokinin-1 receptor.
    Song H; Yin W; Zeng Q; Jia H; Lin L; Liu X; Mu L; Wang R
    Int J Biochem Cell Biol; 2012 Sep; 44(9):1410-21. PubMed ID: 22554585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LW-215, a newly synthesized flavonoid, exhibits potent anti-angiogenic activity in vitro and in vivo.
    Zhao K; Yuan Y; Lin B; Miao Z; Li Z; Guo Q; Lu N
    Gene; 2018 Feb; 642():533-541. PubMed ID: 29196258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of combinations of BMP-2 with FGF-2 and/or VEGF on HUVECs angiogenesis in vitro and CAM angiogenesis in vivo.
    Bai Y; Leng Y; Yin G; Pu X; Huang Z; Liao X; Chen X; Yao Y
    Cell Tissue Res; 2014 Apr; 356(1):109-21. PubMed ID: 24442492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Piceatannol, a Natural Analog of Resveratrol, Exerts Anti-angiogenic Efficiencies by Blockage of Vascular Endothelial Growth Factor Binding to Its Receptor.
    Hu WH; Dai DK; Zheng BZ; Duan R; Dong TT; Qin QW; Tsim KW
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32824997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Graphene Oxides Show Angiogenic Properties.
    Mukherjee S; Sriram P; Barui AK; Nethi SK; Veeriah V; Chatterjee S; Suresh KI; Patra CR
    Adv Healthc Mater; 2015 Aug; 4(11):1722-32. PubMed ID: 26033847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro.
    Cao Z; Lin W; Huang Z; Chen X; Zhao J; Zheng L; Ye H; Liu Z; Liao L; Du J
    Oncol Rep; 2013 Mar; 29(3):1080-6. PubMed ID: 23254951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo.
    Yang BR; Hong SJ; Lee SM; Cong WH; Wan JB; Zhang ZR; Zhang QW; Zhang Y; Wang YT; Lin ZX
    Chin J Integr Med; 2016 Jun; 22(6):420-9. PubMed ID: 25533511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A natural small molecule voacangine inhibits angiogenesis both in vitro and in vivo.
    Kim Y; Jung HJ; Kwon HJ
    Biochem Biophys Res Commun; 2012 Jan; 417(1):330-4. PubMed ID: 22155252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-angiogenic effect of tanshinone IIA involves inhibition of the VEGF/VEGFR2 pathway in vascular endothelial cells.
    Xing Y; Tu J; Zheng L; Guo L; Xi T
    Oncol Rep; 2015 Jan; 33(1):163-70. PubMed ID: 25376085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Pien Tze Huang on angiogenesis in vivo and in vitro.
    Shen AL; Hong F; Liu LY; Lin JM; Zhuang QC; Hong ZF; Peng J
    Chin J Integr Med; 2012 Jun; 18(6):431-6. PubMed ID: 22821655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
    Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Peptide NT/K-CFY Derived from Kringle Structure of Neurotrypsin Inhibits Neovascularization.
    Yao X; Chen C; Zhang J; Xu Y; Xiong S; Gu Q; Xu X; Suo Y
    Curr Eye Res; 2021 Oct; 46(10):1551-1558. PubMed ID: 33870816
    [No Abstract]   [Full Text] [Related]  

  • 40. Sequential delivery of VEGF, FGF-2 and PDGF from the polymeric system enhance HUVECs angiogenesis in vitro and CAM angiogenesis.
    Bai Y; Bai L; Zhou J; Chen H; Zhang L
    Cell Immunol; 2018 Jan; 323():19-32. PubMed ID: 29111157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.